DNA Methylation Changes Directly Cause Schizophrenia Risk, Study Reveals

This groundbreaking study establishes that epigenetic changes directly cause schizophrenia, moving beyond previous research that only showed associations. Understanding these causal relationships could revolutionize how we prevent and treat this devastating mental illness.

Researchers analyzed DNA methylation data from 1,160 brain samples and 27,750 blood samples, comparing them against genetic data from over 130,000 individuals. Using Mendelian randomization—a technique that uses genetic variants as natural experiments—they identified methylation sites that actually cause schizophrenia rather than just correlate with it.

The study revealed 172 brain methylation sites and 157 blood methylation sites that causally influence schizophrenia risk. Remarkably, three sites near genes BRD2, CNNM2, and RERE showed consistent effects in both brain and blood tissue. When researchers compared these findings with gene expression data, they identified 15 genes where both methylation patterns and expression levels contribute to disease risk.

These findings suggest that schizophrenia develops through specific epigenetic mechanisms that could be targeted therapeutically. Unlike genetic mutations, methylation patterns can potentially be modified through interventions, opening new treatment avenues. The validation through genome editing experiments strengthens confidence in these causal relationships.

This research represents a major advance in psychiatric genetics, providing the first clear evidence that epigenetic modifications directly cause schizophrenia rather than simply accompanying it.